secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOCEPT INC (—)
CIK:        0001044378
Form:       8-K
Filed at:   2023-10-16T23:59:59+00:00
Accession:  0001654954-23-012952
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Biocept files Chapter 7 bankruptcy, board and CEO resign
--------------------------------------------------------

- Filed voluntary Chapter 7 petition on October 13, 2023 in Delaware Bankruptcy Court.
- A Chapter 7 trustee will liquidate assets and pay claims per the Bankruptcy Code.
- Entire board (Antonino Morales, Marsha Chandler, Bruce Gerhardt, Quyen Dao-Haddock, Ivor Royston, Linda Rubinstein) resigned effective Oct 13.
- CEO Antonino Morales also resigned as President and CEO effective Oct 13.
- Resignations not due to disagreements but due to the bankruptcy filing eliminating board powers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1044378/000165495423012952/0001654954-23-012952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1044378/000165495423012952/biocept_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-012952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer